1 study found for:    23439259 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Safety and Efficacy of Vaniprevir (MK-7009) Administered With Pegylated Interferon (Peg-IFN) and Ribavirin (RBV) in Treatment-experienced HCV Participants (MK-7009-009)
Condition: Hepatitis C, Chronic
Interventions: Drug: Vaniprevir (600 mg b.i.d.);   Drug: Vaniprevir (300 mg b.i.d.);   Drug: Peg-IFN;   Drug: RBV;   Drug: Placebo

Indicates status has not been verified in more than two years